Dr. Sarah Hamilton is a Radiation Oncologist at BC Cancer in Vancouver, BC, Canada and Clinical Assistant Professor at the University of British Columbia.  She is the Radiation Oncology Residency training program Research Director and is actively involved in the teaching and mentoring of medical students and residents.

Her primary clinical research interests are population based outcomes, treatment related toxicity, and survivorship in head and neck cancer. She is the tumour site lead of the H&N Prospective Outcomes Support Initiative which has collected acute and late patient reported outcomes for over 400 head and neck cancer patients who have undergone radiotherapy at BC Cancer.  She is the principal investigator on a BC Cancer Foundation funded patient recall study evaluating the late effects and screening recommendations in adolescent and young adult survivors of H&N cancer.